Dr. Gutmann received his MD and PhD degrees from the University of Michigan prior to residency training in Neurology at the University of Pennsylvania. Following a post-doctoral research fellowship with Dr. Francis Collins where he identified and characterized the NF1 protein (neurofibromin), Dr. Gutmann joined the faculty in Neurology at the Washington University School of Medicine in late 1993.
His research laboratory employs NF1 as a model genetic system to understand normal growth and differentiation in the normal brain. In this fashion, they aim to characterize the genetic, cellular, and molecular factors that contribute to the development of nervous system tumors (gliomas and neurofibromas) and cognitive problems (learning and attention deficits). Defining these contributing factors represents the first step toward establishing new treatments for children and adults with NF1. Moreover, NF1 provides unique opportunities to unravel the complexities of related medical problems in the general population, including adult and childhood brain tumors, breast cancer, and autism.
In addition, Dr. Gutmann directs the Washington University Neurofibromatosis Center (http://nfcenter.wustl.edu), one of the world's largest basic and clinical science research programs focused on accelerating the pace of scientific discovery and its application to individuals affected with NF.
Our mission is to provide exceptional care through groundbreaking research.
Specialties: Clinical care of children and adults withe neurofibromatosis
Brain tumor and neurofibromatosis research